The Animal Model Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Animal Type (Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Others), By Application (Cancer, Immunological Disease, Infectious Disease, Others), By End-User (Pharmaceutical & Biotechnology Companies, Academic Research Institute, Contract Research Organization).
The Animal Model Market in 2024 is experiencing significant growth, fueled by the increasing demand for preclinical research models, drug discovery platforms, and translational medicine approaches to study human diseases, test therapeutic interventions, and advance biomedical research. Animal models play a crucial role in elucidating disease mechanisms, assessing drug safety and efficacy, and facilitating the development of novel therapies across various therapeutic areas, including oncology, neuroscience, and immunology. With advancements in genetic engineering, genome editing techniques, and imaging technologies, the market offers a diverse range of animal models, including mice, rats, zebrafish, and non-human primates, engineered to recapitulate human disease phenotypes and biological processes. Moreover, the integration of data analytics, in vivo imaging modalities, and patient-derived xenograft models further enhances predictive validity, research reproducibility, and translational relevance, driving market expansion and supporting innovation in preclinical research and drug development.
A notable trend in the Animal Model market is the growing adoption of genetically engineered animal models for biomedical research. Scientists are increasingly utilizing genetically modified animals, such as mice, rats, and zebrafish, to mimic human diseases and conditions, enabling more accurate disease modeling, drug development, and preclinical testing. This trend is driven by advancements in gene editing technologies like CRISPR-Cas9, which allow for precise genetic modifications in animal genomes, resulting in models that better recapitulate human physiology and pathology.
A significant driver propelling the Animal Model market is the increasing demand for preclinical testing services in pharmaceutical and biotechnology industries for drug development purposes. Animal models play a crucial role in evaluating the safety, efficacy, and pharmacokinetics of novel therapeutics before clinical trials in humans, thereby reducing the risk of adverse effects and failures in later stages of drug development. With the growing pipeline of drug candidates and the need for comprehensive preclinical assessment, there is a continuous demand for diverse animal models that can accurately predict drug responses and toxicity profiles.
An opportunity in the Animal Model market lies in the development of humanized animal models tailored for personalized medicine applications. Humanized animal models, created by introducing human cells, tissues, or genes into animals, offer a unique platform for studying disease mechanisms, testing personalized therapies, and conducting translational research. With the increasing emphasis on precision medicine and the need to address genetic variability in drug responses among individuals, there is a growing demand for humanized animal models that can simulate patient-specific conditions and enable personalized treatment strategies. This presents an opportunity for biotechnology companies and research institutions to innovate and commercialize advanced humanized animal models for personalized medicine research and development.
By Animal Type
Mice
Rat
Guinea Pigs
Rabbits
Hamsters
Others
By Application
Cancer
Immunological Disease
Infectious Disease
Others
By End-user
Pharmaceutical & Biotechnology Companies
Academic Research Institute
Contract Research Organization
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
BIOCYTOGEN
BioSpherix Ltd
Charles River Laboratories
Crown Bioscience
genOway
Harbour BioMed
Inotiv
Janvier Labs
Taconic Biosciences Inc
The Jackson Laboratory
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Animal Model Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Animal Model Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Animal Model Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Animal Model Market Size Outlook, $ Million, 2021 to 2030
3.2 Animal Model Market Outlook by Type, $ Million, 2021 to 2030
3.3 Animal Model Market Outlook by Product, $ Million, 2021 to 2030
3.4 Animal Model Market Outlook by Application, $ Million, 2021 to 2030
3.5 Animal Model Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Animal Model Market Industry
4.2 Key Market Trends in Animal Model Market Industry
4.3 Potential Opportunities in Animal Model Market Industry
4.4 Key Challenges in Animal Model Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Animal Model Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Animal Model Market Outlook By Segments
7.1 Animal Model Market Outlook by Segments
By Animal Type
Mice
Rat
Guinea Pigs
Rabbits
Hamsters
Others
By Application
Cancer
Immunological Disease
Infectious Disease
Others
By End-user
Pharmaceutical & Biotechnology Companies
Academic Research Institute
Contract Research Organization
8 North America Animal Model Market Analysis And Outlook To 2030
8.1 Introduction to North America Animal Model Markets in 2024
8.2 North America Animal Model Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Animal Model Market size Outlook by Segments, 2021-2030
By Animal Type
Mice
Rat
Guinea Pigs
Rabbits
Hamsters
Others
By Application
Cancer
Immunological Disease
Infectious Disease
Others
By End-user
Pharmaceutical & Biotechnology Companies
Academic Research Institute
Contract Research Organization
9 Europe Animal Model Market Analysis And Outlook To 2030
9.1 Introduction to Europe Animal Model Markets in 2024
9.2 Europe Animal Model Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Animal Model Market Size Outlook By Segments, 2021-2030
By Animal Type
Mice
Rat
Guinea Pigs
Rabbits
Hamsters
Others
By Application
Cancer
Immunological Disease
Infectious Disease
Others
By End-user
Pharmaceutical & Biotechnology Companies
Academic Research Institute
Contract Research Organization
10 Asia Pacific Animal Model Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Animal Model Markets in 2024
10.2 Asia Pacific Animal Model Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Animal Model Market size Outlook by Segments, 2021-2030
By Animal Type
Mice
Rat
Guinea Pigs
Rabbits
Hamsters
Others
By Application
Cancer
Immunological Disease
Infectious Disease
Others
By End-user
Pharmaceutical & Biotechnology Companies
Academic Research Institute
Contract Research Organization
11 South America Animal Model Market Analysis And Outlook To 2030
11.1 Introduction to South America Animal Model Markets in 2024
11.2 South America Animal Model Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Animal Model Market size Outlook by Segments, 2021-2030
By Animal Type
Mice
Rat
Guinea Pigs
Rabbits
Hamsters
Others
By Application
Cancer
Immunological Disease
Infectious Disease
Others
By End-user
Pharmaceutical & Biotechnology Companies
Academic Research Institute
Contract Research Organization
12 Middle East And Africa Animal Model Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Animal Model Markets in 2024
12.2 Middle East and Africa Animal Model Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Animal Model Market size Outlook by Segments, 2021-2030
By Animal Type
Mice
Rat
Guinea Pigs
Rabbits
Hamsters
Others
By Application
Cancer
Immunological Disease
Infectious Disease
Others
By End-user
Pharmaceutical & Biotechnology Companies
Academic Research Institute
Contract Research Organization
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
BIOCYTOGEN
BioSpherix Ltd
Charles River Laboratories
Crown Bioscience
genOway
Harbour BioMed
Inotiv
Janvier Labs
Taconic Biosciences Inc
The Jackson Laboratory
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Animal Type
Mice
Rat
Guinea Pigs
Rabbits
Hamsters
Others
By Application
Cancer
Immunological Disease
Infectious Disease
Others
By End-user
Pharmaceutical & Biotechnology Companies
Academic Research Institute
Contract Research Organization
The global Animal Model Market is one of the lucrative growth markets, poised to register a 12.6% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
BIOCYTOGEN, BioSpherix Ltd, Charles River Laboratories, Crown Bioscience, genOway, Harbour BioMed, Inotiv, Janvier Labs, Taconic Biosciences Inc, The Jackson Laboratory
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume